University of Pennslvania Abramson Cancer Center — Philadelphia, Pennsylvania

University of Pennslvania Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Pennslvania Abramson Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma.

Sponsors: Traws Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennslvania Abramson Cancer Center?

University of Pennslvania Abramson Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennslvania Abramson Cancer Center conducted?

University of Pennslvania Abramson Cancer Center has 1 clinical trials on record. Their work covers Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma.

Is University of Pennslvania Abramson Cancer Center accredited by Crixeo Health?

University of Pennslvania Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Pennslvania Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.